Skip to search boxSkip to navigationSkip to main content

Toxic neurofilamentous axonopathies and fast axonal transport. v. reduced bidirectional vesicle transport in cultured neurons by acrylamide and glycidamide

  • C. H. Harris
    ,
  • A. K. Gulati
    ,
  • M. A. Friedman
    ,
  • D. W. Sickles(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Fast axonal transport deficiencies as mechanisms of action of aoylamide in producing axonal degeneration are under evaluation. The current study determines the effects of acry- lamide and several analogues on the number of vesicles moving within the neurite processes of cultured rat embryonic neurons. Acrylamide produced severe, concentration- dependent (0.25-1.0 mM) and time-dependent (0-60 min) reduction in the quantity of vesicles translocated in both the anterograde and retrograde directions. Clycidamide, a potential neurotoxic metabolite of acrylamide, produced a time-dependent but not a concentration-dependent (in the 0.25-1.0 mM range) reduction in bidirectional transport. Based on inhibition at 60 min, glycidamide was estimated to be 4 times more potent than acrylamide in altering transport. Propionamide, a C1,-C2saturated nonneurotoxic acrylamide analogue, had no effect on axonal transport. While a tendency for methylene bisacrylamide (MbACR) to reduce vesicle transport was noted, at the concentration used no statistically significant differences from control were observed. The data support the correlation between toxicant-induced fast anterograde and retrograde axonal transport reductions and axonal degeneration produced by acrylamide and its analogues.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 343-356 (14 pages)

Journal (Volume, Issue Number)

Journal of Toxicology and Environmental Health (Volume 42, Issue 3)

Publication milestones

  • Published - 07/1994

Publication status

Published - 07/1994

ISSN

0098-4108

Publication IDs

  • Scopus: 0028175589
  • PubMed: 7517455

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
7
Citation count
20

Funding Details

Received 9 April 1993; accepted 8 December 1993. Funding for this study was provided by American Cyanamid Company, Wayne, N.J. Address correspondenceto D. W. Sickles, Department of Cellular Biology and Anatomy, College of Georgia, Augusta, CA 30912-2000, USA.